Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingzhou Guo

Showing results (51-60 of 163) with videos related to

Pageof 17
Sort By:
Journal of Translational Internal Medicine|July 31, 2024
Methylation of <i>FAM110C</i> is a synthetic lethal marker for ATR/CHK1 inhibitors in pancreatic cancerFengna Liu, Aiai Gao, Meiying Zhang, et al.
Genes & Cancer|July 1, 2015
RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant markerYongshuai Jin, Baoping Cao, Meiying Zhang, et al.
Cancer Science|May 1, 2021
Methylation of NRN1 is a novel synthetic lethal marker of PI3K-Akt-mTOR and ATR inhibitors in esophageal cancerWushuang Du, Aiai Gao, James G Herman, et al.
Molecular and Cellular Biochemistry|March 19, 2011
Differential expression of oncogenic miRNAs in proliferating and senescent human fibroblastsMiao Wang, Zhaojie Cheng, Tian Tian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagusMingzhou Guo, Jingli Ren, Michael G House, et al.
Clinical Epigenetics|May 26, 2018
Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancerWenji Yan, Kongming Wu, James G Herman, et al.
Chemmedchem|February 16, 2017
Synthesis of 5α,8α-Ergosterol Peroxide 3-Carbamate Derivatives and a Fluorescent Mitochondria-Targeting Conjugate for Enhanced Anticancer ActivitiesMing Bu, Tingting Cao, Hongxia Li, et al.
Epigenomics|April 14, 2017
Methylation of SLFN11 is a marker of poor prognosis and cisplatin resistance in colorectal cancerTao He, Meiying Zhang, Ruipan Zheng, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 22, 2014
Predictive value of CHFR and MLH1 methylation in human gastric cancerYazhuo Li, Yunsheng Yang, Youyong Lu, et al.
Plos One|November 7, 2014
Methylation of DACT2 promotes papillary thyroid cancer metastasis by activating Wnt signalingZhiyan Zhao, James G Herman, Malcolm V Brock, et al.
Pageof 17

Showing results (51-60 of 163) with videos related to

Sort By:
Pageof 17
Journal of Translational Internal Medicine|July 31, 2024
Methylation of <i>FAM110C</i> is a synthetic lethal marker for ATR/CHK1 inhibitors in pancreatic cancerFengna Liu, Aiai Gao, Meiying Zhang, et al.
Genes & Cancer|July 1, 2015
RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant markerYongshuai Jin, Baoping Cao, Meiying Zhang, et al.
Cancer Science|May 1, 2021
Methylation of NRN1 is a novel synthetic lethal marker of PI3K-Akt-mTOR and ATR inhibitors in esophageal cancerWushuang Du, Aiai Gao, James G Herman, et al.
Molecular and Cellular Biochemistry|March 19, 2011
Differential expression of oncogenic miRNAs in proliferating and senescent human fibroblastsMiao Wang, Zhaojie Cheng, Tian Tian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagusMingzhou Guo, Jingli Ren, Michael G House, et al.
Clinical Epigenetics|May 26, 2018
Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancerWenji Yan, Kongming Wu, James G Herman, et al.
Chemmedchem|February 16, 2017
Synthesis of 5α,8α-Ergosterol Peroxide 3-Carbamate Derivatives and a Fluorescent Mitochondria-Targeting Conjugate for Enhanced Anticancer ActivitiesMing Bu, Tingting Cao, Hongxia Li, et al.
Epigenomics|April 14, 2017
Methylation of SLFN11 is a marker of poor prognosis and cisplatin resistance in colorectal cancerTao He, Meiying Zhang, Ruipan Zheng, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 22, 2014
Predictive value of CHFR and MLH1 methylation in human gastric cancerYazhuo Li, Yunsheng Yang, Youyong Lu, et al.
Plos One|November 7, 2014
Methylation of DACT2 promotes papillary thyroid cancer metastasis by activating Wnt signalingZhiyan Zhao, James G Herman, Malcolm V Brock, et al.
Pageof 17